Literature DB >> 11483205

The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds.

J Schuurman1, G J Perdok, A D Gorter, R C Aalberse.   

Abstract

Unlike other immunoglobulin G (IgG) subclasses, IgG4 antibodies in plasma have been reported to be functionally monovalent. In a previous paper, we showed that the apparent monovalency of circulating IgG4 antibodies is caused by asymmetry of plasma IgG4-a large fraction has two antigen-binding sites resulting in bispecificity. We postulated that the generation of bispecific antibodies was caused by a post-secretion mechanism, involving the exchange of IgG4 half-molecules (i.e. one heavy and one light chain). This hypothesis was based on the observed instability of the inter-heavy chain disulfide bonds of IgG4. To investigate this instability, we constructed IgG4 mutants and analyzed the covalent interaction between the heavy chains by sodium dodecyl sulfate-poly acrylamide gel electrophoresis (SDS-PAGE) under non-reducing conditions. The mutation to serine of one of the hinge cysteines involved in the inter-heavy chain bond formation, Cys226, resulted in a more stable rather than a more labile inter-heavy chain linkage. Moreover, we confirmed that mutating the IgG4 hinge sequence Cys-Pro-Ser-Cys to the IgG1 hinge sequence Cys-Pro-Pro-Cys also markedly stabilizes the covalent interaction between the heavy-chains. These two observations suggested an explanation for the observed instability of the inter-heavy chain disulfide bonds: the formation of an alternative, intra-chain cystine. Obviously, this intra-chain cystine cannot be formed in the mutant where Cys226 is replaced by Ser, and cannot easily be formed in the mutant with the IgG1 hinge sequence (Cys-Pro-Pro-Cys) due to the restricted torsional freedom of prolines. We, therefore, postulate that the lack of a covalent heavy-chain interaction in a subpopulation of IgG4 reflects an equilibrium between inter- and intra-chain cystines. Based upon the published structure of the IgG4-related hinge-deleted IgG1 myeloma protein Mcg, we propose a model for the two forms of IgG4 and for the half-molecule exchange reaction, which might result in the formation of bispecific IgG4 antibodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483205     DOI: 10.1016/s0161-5890(01)00050-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  56 in total

1.  Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.

Authors:  James T Heads; Ralph Adams; Lena E D'Hooghe; Matt J T Page; David P Humphreys; Andrew G Popplewell; Alastair D Lawson; Alistair J Henry
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

Review 2.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

3.  Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability.

Authors:  Shirley J Peters; C Mark Smales; Alistair J Henry; Paul E Stephens; Shauna West; David P Humphreys
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

Review 4.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

Review 5.  [Immunological principles of IgG4 related diseases].

Authors:  T Witte
Journal:  Radiologe       Date:  2016-12       Impact factor: 0.635

6.  Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.

Authors:  Lily Pei-Yao Liu-Shin; Adam Fung; Arun Malhotra; Gayathri Ratnaswamy
Journal:  MAbs       Date:  2018-10-19       Impact factor: 5.857

7.  The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.

Authors:  John-Paul Silva; Olivia Vetterlein; Joby Jose; Shirley Peters; Hishani Kirby
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

8.  Monovalent IgG4 molecules: immunoglobulin Fc mutations that result in a monomeric structure.

Authors:  Ian C Wilkinson; Susan B Fowler; Leeann Machiesky; Kenneth Miller; David B Hayes; Morshed Adib; Cheng Her; M Jack Borrok; Ping Tsui; Matthew Burrell; Dominic J Corkill; Susanne Witt; David C Lowe; Carl I Webster
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

Review 9.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

10.  Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo.

Authors:  Aran F Labrijn; Antonio Ortiz Buijsse; Ewald T J van den Bremer; Annemiek Y W Verwilligen; Wim K Bleeker; Susan J Thorpe; Joep Killestein; Chris H Polman; Rob C Aalberse; Janine Schuurman; Jan G J van de Winkel; Paul W H I Parren
Journal:  Nat Biotechnol       Date:  2009-07-20       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.